J Cancer 2014; 5(8):715-719. doi:10.7150/jca.9971 This issue Cite

Review

Salamander Regeneration as a Model for Developing Novel Regenerative and Anticancer Therapies

Jonathan Fior

Innovative Bioresearch, Milan, Italy.

Citation:
Fior J. Salamander Regeneration as a Model for Developing Novel Regenerative and Anticancer Therapies. J Cancer 2014; 5(8):715-719. doi:10.7150/jca.9971. https://www.jcancer.org/v05p0715.htm
Other styles

File import instruction

Abstract

Among vertebrates, urodele amphibians are the only tetrapods with the ability to regenerate complex structures such as limbs, tail, and spinal cord throughout their lives. Furthermore, the salamander regeneration process has been shown to reverse tumorigenicity. Fibroblasts are essential for salamander regeneration, but the mechanisms underlying their role in the formation of a regeneration blastema remain unclear. Here, I review the role of fibroblasts in salamander limb regeneration and how their activity compares with that of human fibroblasts. In addition, the question of whether salamander blastema tissue could induce regeneration and tumor regression in animals with a limited regeneration ability is discussed. A deeper understanding of these processes may lead to the development of novel regenerative and anticancer therapies.

Keywords: salamander regeneration, wound healing, tumor progression, fibroblasts.


Citation styles

APA
Fior, J. (2014). Salamander Regeneration as a Model for Developing Novel Regenerative and Anticancer Therapies. Journal of Cancer, 5(8), 715-719. https://doi.org/10.7150/jca.9971.

ACS
Fior, J. Salamander Regeneration as a Model for Developing Novel Regenerative and Anticancer Therapies. J. Cancer 2014, 5 (8), 715-719. DOI: 10.7150/jca.9971.

NLM
Fior J. Salamander Regeneration as a Model for Developing Novel Regenerative and Anticancer Therapies. J Cancer 2014; 5(8):715-719. doi:10.7150/jca.9971. https://www.jcancer.org/v05p0715.htm

CSE
Fior J. 2014. Salamander Regeneration as a Model for Developing Novel Regenerative and Anticancer Therapies. J Cancer. 5(8):715-719.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image